EWU Institutional Repository

Prospect of Ertapenem in Bangladesh Pharmaceutical Market

Show simple item record

dc.contributor.author Vasha, Raktim Kar
dc.date.accessioned 2019-02-26T09:46:35Z
dc.date.available 2019-02-26T09:46:35Z
dc.date.issued 12/24/2009
dc.identifier.uri http://dspace.ewubd.edu/handle/2525/2958
dc.description This thesis submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy (B.Pharm) in East West University, Dhaka, Bangladesh. en_US
dc.description.abstract Ertapenem is a sterile, synthetic, parenteral, I-~ methyl-carbapenem that is structurally related to beta-lactam antibiotics. Ertapenem, a Group 1 carbapenem, is most recently introduced into the market and cover both Gram positive and Gram negative pathogens. Here the objective is to find the characteristics of ertapenem in the treatment of complicated infectious diseases and establish demonstrated safety profile and clinical efficacy of ertapenem against complicated diseases. This report is fully based on secondary data which I have collected from many journals, IMS, MIMS, browsing different web sites. From this research it was found that ertapenem shows excellent success in complicated infectious diseases. By doing market strategy regarding IMS data it is assume that if it is launched in the market the total market size will be 31,087,084 within 1-2 years which makes the drug feasible in the market. en_US
dc.language.iso en_US en_US
dc.publisher East West University en_US
dc.relation.ispartofseries ;PHA00043
dc.subject Ertapenem in Bangladesh Pharmaceutical Market en_US
dc.title Prospect of Ertapenem in Bangladesh Pharmaceutical Market en_US
dc.type Thesis en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account